SiBionics announced that it has raised CNY 500 million in a round of funding led by Shanghai Biomedical Industry Equity Investment Fund Partnership (LP), a fund managed by Shanghai Shangshi Capital Management Co., Ltd. and Guangdong Traditional Chinese Medicine Great Health Equity Investment Fund Partnership Ent. (L.P.), a fund managed by Guangdong Kaiheng Private Equity Investment Fund Management Co., Ltd. in December 21, 2022. The transaction also included participation from Next Capital, China Industrial Securities International Capital Limited and China New Town Development Company Limited.